{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:28:38Z","timestamp":1773696518966,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T00:00:00Z","timestamp":1480377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/tpj.2016.74","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T11:01:59Z","timestamp":1480417319000},"page":"121-126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Increasing BMI is associated with reduced expression of P-glycoprotein (ABCB1 gene) in the human brain with a stronger association in African Americans than Caucasians"],"prefix":"10.1038","volume":"18","author":[{"given":"J","family":"Vendelbo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R H","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J K","family":"Lauridsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Rungby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J E","family":"Kleinman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T M","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8765-8443","authenticated-orcid":false,"given":"A","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,29]]},"reference":[{"key":"BFtpj201674_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ana.21012","volume":"60","author":"DM Hermann","year":"2006","unstructured":"Hermann DM, Kilic E, Spudich A, Kr\u00e4mer SD, Wunderli-Allenspach H, Bassetti CL . Role of drug efflux carriers in the healthy and diseased brain. Ann Neurol 2006; 60: 489\u2013498.","journal-title":"Ann Neurol"},{"key":"BFtpj201674_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1517\/17425255.1.2.233","volume":"1","author":"J-M Scherrmann","year":"2005","unstructured":"Scherrmann J-M . Expression and function of multidrug resistance transporters at the blood-brain barriers. Expert Opin Drug Metab Toxicol 2005; 1: 233\u2013246.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"BFtpj201674_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1073\/pnas.86.2.695","volume":"86","author":"C Cordon-cardo","year":"1989","unstructured":"Cordon-cardo C, Brien JPO, Casals D, Rittman-grauert L, Biedler JL, Melamed MR et al. Multidrug-resistance (P-glycoprotein). Proc Natl Acad Sci USA 1989; 86: 695\u2013698.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtpj201674_CR4","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1073\/pnas.96.7.3900","volume":"96","author":"VV Rao","year":"1999","unstructured":"Rao VV, Dahlheimer JL, Bardgett ME, Snyder a Z, Finch Ra, Sartorelli a C et al. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc Natl Acad Sci USA 1999; 96: 3900\u20133905.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtpj201674_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.clpt.2003.09.012","volume":"75","author":"C Marzolini","year":"2004","unstructured":"Marzolini C, Paus E, Buclin T, Kim RB . Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther 2004; 75: 13\u201333.","journal-title":"Clin Pharmacol Ther"},{"key":"BFtpj201674_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.cbi.2009.04.012","volume":"180","author":"ILMH Aye","year":"2009","unstructured":"Aye ILMH, Singh AT, Keelan JA . Transport of lipids by ABC proteins: interactions and implications for cellular toxicity, viability and function. Chem Biol Interact 2009; 180: 327\u2013339.","journal-title":"Chem Biol Interact"},{"key":"BFtpj201674_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/00008571-200308000-00006","volume":"13","author":"DL Kroetz","year":"2003","unstructured":"Kroetz DL, Pauli-Magnus C, Hodges LM, Huang CC, Kawamoto M, Johns SJ et al. Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics 2003; 13: 481\u2013494.","journal-title":"Pharmacogenetics"},{"key":"BFtpj201674_CR8","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","volume":"97","author":"S Hoffmeyer","year":"2000","unstructured":"Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockm\u00f6ller J, Johne A et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97: 3473\u20133478.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtpj201674_CR9","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/j.1528-1167.2008.01661.x","volume":"49","author":"I Mosyagin","year":"2008","unstructured":"Mosyagin I, Runge U, Schroeder HW, Dazert E, Vogelgesang S, Siegmund W et al. Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients. Epilepsia 2008; 49: 1555\u20131561.","journal-title":"Epilepsia"},{"key":"BFtpj201674_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/01.fpc.0000178311.02878.83","volume":"15","author":"D Wang","year":"2005","unstructured":"Wang D, Johnson AD, Papp AC, Kroetz DL, Sad\u00e9e W . Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genomics 2005; 15: 693\u2013704.","journal-title":"Pharmacogenet Genomics"},{"key":"BFtpj201674_CR11","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2217\/pgs.11.55","volume":"12","author":"T Moons","year":"2011","unstructured":"Moons T, Roo Mde, Claes S, Dom G . Relationship between P-glycoprotein and second-generation antipsychotics. Pharmacogenomics 2011; 12: 1193\u20131211.","journal-title":"Pharmacogenomics"},{"key":"BFtpj201674_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1080\/0092623X.2011.615896","volume":"39","author":"MJ Bly","year":"2013","unstructured":"Bly MJ, Bishop JR, Thomas KLH, Ellingrod VL . P-glycoprotein (P-GP) polymorphisms and sexual dysfunction in female patients with depression and SSRI-associated sexual side effects. J Sex Marital Ther 2013; 39: 280\u2013288.","journal-title":"J Sex Marital Ther"},{"key":"BFtpj201674_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/sj.tpj.6500099","volume":"2","author":"RL Roberts","year":"2002","unstructured":"Roberts RL, Joyce PR, Mulder RT, Begg EJ, Kennedy MA . A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression. Pharmacogenomics J 2002; 2: 191\u2013196.","journal-title":"Pharmacogenomics J"},{"key":"BFtpj201674_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/tpj.2012.16","volume":"13","author":"OL De Klerk","year":"2013","unstructured":"De Klerk OL, Nolte IM, Bet PM, Bosker FJ, Snieder H, den Boer Ja et al. ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder. Pharmacogenomics J 2013; 13: 349\u2013353.","journal-title":"Pharmacogenomics J"},{"key":"BFtpj201674_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/JCP.0b013e3182905a8d","volume":"33","author":"SW Kim","year":"2013","unstructured":"Kim SW, Lee JH, Lee SH, Hong HJ, Lee MG, Yook K-H . ABCB1 c.2677G>T variation is associated with adverse reactions of OROS-methylphenidate in children and adolescents with ADHD. J Clin Psychopharmacol 2013; 33: 491\u2013498.","journal-title":"J Clin Psychopharmacol"},{"key":"BFtpj201674_CR16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.psychres.2007.06.006","volume":"160","author":"MR Kuzman","year":"2008","unstructured":"Kuzman MR, Medved V, Bozina N, Hotujac L, Sain I, Bilusic H . The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients. Psychiatry Res 2008; 160: 308\u2013315.","journal-title":"Psychiatry Res"},{"key":"BFtpj201674_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/tpj.2010.7","volume":"11","author":"MR Kuzman","year":"2011","unstructured":"Kuzman MR, Medved V, Bozina N, Grubi\u0161in J, Jovanovic N, Sertic J . Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia. Pharmacogenomics J 2011; 11: 35\u201344.","journal-title":"Pharmacogenomics J"},{"key":"BFtpj201674_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","volume":"377","author":"MM Finucane","year":"2011","unstructured":"Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9\u00b71 million participants. Lancet 2011; 377: 557\u2013567.","journal-title":"Lancet"},{"key":"BFtpj201674_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ygeno.2008.03.004","volume":"91","author":"S Ichihara","year":"2008","unstructured":"Ichihara S, Yamada Y, Kato K, Hibino T, Yokoi K, Matsuo H et al. Association of a polymorphism of ABCB1 with obesity in Japanese individuals. Genomics 2008; 91: 512\u2013516.","journal-title":"Genomics"},{"key":"BFtpj201674_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature10524","volume":"478","author":"C Colantuoni","year":"2011","unstructured":"Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 478: 519\u2013523.","journal-title":"Nature"},{"key":"BFtpj201674_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ajhg.2011.12.020","volume":"90","author":"S Numata","year":"2012","unstructured":"Numata S, Ye T, Hyde TM, Guitart-Navarro X, Tao R, Wininger M et al. DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet 2012; 90: 260\u2013272.","journal-title":"Am J Hum Genet"},{"key":"BFtpj201674_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.euroneuro.2007.06.003","volume":"18","author":"K Linnet","year":"2008","unstructured":"Linnet K, Ejsing TB . A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs. Eur Neuropsychopharmacol 2008; 18: 157\u2013169.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtpj201674_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2133\/dmpk.DMPK-13-RG-110","volume":"29","author":"K Sawamoto","year":"2014","unstructured":"Sawamoto K, Huong T, Sugimoto N, Mizutani Y, Sai Y, Miyamoto K . Mechanisms of lower maintenance dose of tacrolimus in obese patients. Drug Metab Pharmacokinet 2014; 29: 341\u2013347.","journal-title":"Drug Metab Pharmacokinet"},{"key":"BFtpj201674_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/PL00000257","volume":"50","author":"M Sukhai","year":"2001","unstructured":"Sukhai M, Yong A, Pak A, Piquette-Miller M . Decreased expression of P-glycoprotein in interleukin-1beta and interleukin-6 treated rat hepatocytes. Inflamm Res 2001; 50: 362\u2013370.","journal-title":"Inflamm Res"},{"key":"BFtpj201674_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/mcbr.2001.0288","volume":"4","author":"M Sukhai","year":"2000","unstructured":"Sukhai M, Yong A, Kalitsky J, Piquette-Miller M . Inflammation and interleukin-6 mediate reductions in the hepatic expression and transcription of the mdr1a and mdr1b genes. Mol Cell Biol Res Commun 2000; 4: 248\u2013256.","journal-title":"Mol Cell Biol Res Commun"},{"key":"BFtpj201674_CR26","doi-asserted-by":"publisher","first-page":"e43002","DOI":"10.1371\/journal.pone.0043002","volume":"7","author":"M Iqbal","year":"2012","unstructured":"Iqbal M, Ho HL, Petropoulos S, Moisiadis VG, Gibb W, Matthews SG . Pro-inflammatory cytokine regulation of P-glycoprotein in the developing blood-brain barrier. PLos One 2012; 7: e43002.","journal-title":"PLos One"},{"key":"BFtpj201674_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10571-009-9431-1","volume":"30","author":"B Poller","year":"2010","unstructured":"Poller B, Drewe J, Kr\u00e4henb\u00fchl S, Huwyler J, Gutmann H . Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier. Cell Mol Neurobiol 2010; 30: 63\u201370.","journal-title":"Cell Mol Neurobiol"},{"key":"BFtpj201674_CR28","doi-asserted-by":"publisher","first-page":"e23614","DOI":"10.1371\/journal.pone.0023614","volume":"6","author":"M Foucaud-Vignault","year":"2011","unstructured":"Foucaud-Vignault M, Soayfane Z, M\u00e9nez C, Bertrand-Michel J, Martin P-GP, Guillou H et al. P-glycoprotein dysfunction contributes to hepatic steatosis and obesity in mice. PLoS One 2011; 6: e23614.","journal-title":"PLoS One"},{"key":"BFtpj201674_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cca.2009.02.019","volume":"403","author":"E Jeannesson","year":"2009","unstructured":"Jeannesson E, Siest G, Bastien B, Albertini L, Aslanidis C, Schmitz G et al. Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the STANISLAS cohort. Clin Chim Acta 2009; 403: 198\u2013202.","journal-title":"Clin Chim Acta"},{"key":"BFtpj201674_CR30","doi-asserted-by":"publisher","first-page":"714","DOI":"10.4238\/2013.March.11.20","volume":"12","author":"A Mencalha","year":"2013","unstructured":"Mencalha A, Rodrigues E . Accurate monitoring of promoter gene methylation with high-resolution melting polymerase chain reaction using the ABCB1 gene as a model. Genet Mol Res 2013; 12: 714\u2013722.","journal-title":"Genet Mol Res"},{"key":"BFtpj201674_CR31","first-page":"2396","volume":"17","author":"J Suliburska","year":"2013","unstructured":"Suliburska J, Cofta S, Kalmus G, Sobieska M, Samborski W, Krejpcio Z et al. The evaluation of selected serum mineral concentrations and their association with insulin resistance in obese adolescents. Eur Rev Med Pharmacol Sci 2013; 17: 2396\u20132400.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"BFtpj201674_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1470-2045(02)00849-5","volume":"3","author":"F Bianchini","year":"2002","unstructured":"Bianchini F, Kaaks R, Vainio H . Overweight, obesity, and cancer risk. Lancet Oncol 2002; 3: 565\u2013574.","journal-title":"Lancet Oncol"},{"key":"BFtpj201674_CR33","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmod K, Thun MJ . Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625\u20131638.","journal-title":"N Engl J Med"},{"key":"BFtpj201674_CR34","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/01635581.2013.805794","volume":"65","author":"G Supic","year":"2013","unstructured":"Supic G, Jagodic M, Magic Z . Epigenetics: a new link between nutrition and cancer. Nutr Cancer 2013; 65: 781\u2013792.","journal-title":"Nutr Cancer"},{"key":"BFtpj201674_CR35","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2217\/pgs.14.58","volume":"15","author":"KW Kenneth","year":"2014","unstructured":"Kenneth KW, To, MH, BT . Expression and activity of ABCG2, but not ABCB1 or OATP1B1, are associated with cholesterol levels: evidence from in vitro and in vivo experiments. Pharmacogenomics 2014; 15: 1091\u20131104.","journal-title":"Pharmacogenomics"},{"key":"BFtpj201674_CR36","unstructured":"Fryar CD, Hirsch R, Eberhardt MS, Yoon SS, Wright JD . Hypertension, high serum total cholesterol, and diabetes: racial and ethnic prevalence differences in U.S. adults, 1999-2006. NCHS Data Brief, 2008, pp 1\u20138."},{"key":"BFtpj201674_CR37","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/sj.ijo.0800741","volume":"22","author":"P Deurenberg","year":"1998","unstructured":"Deurenberg P, Yap M, van Staveren WA . Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998; 22: 1164\u20131171.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BFtpj201674_CR38","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S2213-8587(15)00033-9","volume":"3","author":"N Qizilbash","year":"2015","unstructured":"Qizilbash N, Gregson J, Johnson ME, Pearce N, Douglas I, Wing K et al. BMI and risk of dementia in two million people over two decades: a retrospective cohort. Lancet Diabetes Endocrinol 2015; 3: 431\u2013436.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"BFtpj201674_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/156720507780362047","volume":"4","author":"RA Whitmer","year":"2007","unstructured":"Whitmer RA, Gunderson EP, Quesenberry CP Jr, Zhou J, Yaffe K . Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res 2007; 4: 103\u2013109.","journal-title":"Curr Alzheimer Res"},{"key":"BFtpj201674_CR40","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1212\/01.wnl.0000306313.89165.ef","volume":"71","author":"RA Whitmer","year":"2008","unstructured":"Whitmer RA, Gustafson DR, Barret-Connor E, Haan MN, Gunderson EP, Yaffe K . Central obesity and increased risk of dementia more than three decades later. Neurology 2008; 71: 1057\u20131064.","journal-title":"Neurology"},{"key":"BFtpj201674_CR41","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1212\/WNL.0b013e3182190d09","volume":"76","author":"WL Xu","year":"2011","unstructured":"Xu WL, Atti AR, Gatz M, Pedersen NL, Johansson B, Fratiglioni L . Midlife overweight and obesity increases late-life dementia risk: a population-based twin study. Neurology 2011; 76: 1568\u20131574.","journal-title":"Neurology"},{"key":"BFtpj201674_CR42","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1111\/j.1467-789X.2010.00825.x","volume":"12","author":"KJ Anstey","year":"2011","unstructured":"Anstey KJ, Cherbuin N, Budge M, Young J . Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev 2011; 12: e426\u2013e437.","journal-title":"Obes Rev"},{"key":"BFtpj201674_CR43","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1172\/JCI25247","volume":"115","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, Deane R, Fagan AM, Spinner ML, Parasadanian M, Finn MG et al. P-glycoprotien deficiency at the blood-brain barrier increases amyloid-beta deposition in a Alzheimer disease model mouse. J Clin Invest 2005; 115: 3285\u20133290.","journal-title":"J Clin Invest"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/tpj201674.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/tpj201674","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/tpj.2016.74","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/tpj201674.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:47:43Z","timestamp":1684622863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tpj201674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,29]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFtpj201674"],"URL":"https:\/\/doi.org\/10.1038\/tpj.2016.74","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,29]]},"assertion":[{"value":"28 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}